Ind-Swift Laboratories (NSE:INDSWFTLAB) Current Accrued Expense : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Ind-Swift Laboratories Current Accrued Expense?

Ind-Swift Laboratories's Current Accrued Expense for the quarter that ended in Dec. 2023 was ₹0 Mil.

Ind-Swift Laboratories Current Accrued Expense Historical Data

The historical data trend for Ind-Swift Laboratories's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ind-Swift Laboratories Current Accrued Expense Chart

Ind-Swift Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Current Accrued Expense

Get a 7-Day Free Trial

Ind-Swift Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Current Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Ind-Swift Laboratories Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Ind-Swift Laboratories Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Ind-Swift Laboratories's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) » Definitions » Current Accrued Expense

Traded in Other Exchanges

532305:India

Address

SCO 850, Shivalik Enclave, NAC, Manimajra, Chandigarh, PB, IND, 160 101

Website

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd is engaged in the business of active pharmaceutical ingredients (API). The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. Geographically, it derives a majority of revenue from Outside India.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Headlines

No Headlines